TIM-3 expression was observed in cancer cells (both primary and cell lines) sampled from lung [105,106], gastric [104] and cervical cancers [107], osteosarcoma [108], clear cell RCC [109], as well as melanoma [110] and leukemia stem cells [111,112]. This evidence concerns the gene HAVCR2 and cervical carcinoma.